+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stomach Cancer Treatment Market - Global Forecast 2025-2030- Product Image
Stomach Cancer Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Stomach Cancer Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012198
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The stomach cancer treatment market is advancing rapidly, propelled by emerging therapies and evolving care models. Senior decision-makers seeking actionable intelligence will find critical insights in this comprehensive research, enabling well-informed strategic planning across global oncology operations.

Market Snapshot: Stomach Cancer Treatment

The stomach cancer treatment market grew from USD 5.55 billion in 2024 to USD 6.10 billion in 2025. It is expected to continue growing at a CAGR of 9.63%, reaching USD 9.64 billion by 2030. This robust expansion is fueled by breakthroughs in immunotherapy, targeted therapy, and the integration of digital health platforms into clinical pathways. Established and emerging regions are recalibrating therapeutic offerings and investment strategies to meet rising demand and evolving patient needs.

Scope & Segmentation

This report delivers a granular breakdown of the stomach cancer treatment market, examining treatment modalities, patient populations, distribution channels, and regional variances. Key areas analyzed include:

  • Treatment Types: Chemotherapy (fluorouracil-based, platinum-based, taxane-based), Immunotherapy (CTLA-4 inhibitors, PD-1 inhibitors), Radiotherapy (brachytherapy, external beam), Surgery (partial gastrectomy, total gastrectomy), Targeted Therapy (EGFR, HER2, VEGF inhibitors)
  • Routes of Administration: Intravenous and oral formulations, which influence outpatient versus inpatient care models and patient adherence dynamics
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy, supporting diverse approaches to patient access
  • Disease Stages: Stage I, II, III, and IV, spanning curative-focused to palliative and combination regimens
  • End Users: Hospitals, homecare environments, and specialty oncology clinics, each presenting unique resource and support needs
  • Histologic Types: Adenocarcinoma, carcinoid tumors, GIST, lymphoma, affecting therapeutic decisions and patient outcomes
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, Japan, India, Australia, and others)
  • Technologies in Focus: Molecular diagnostics, precision radiation techniques, real-world data integration, and minimally invasive surgical advancements
  • Leading Companies: Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, Takeda, Daiichi Sankyo, Sanofi, Pfizer, Amgen

Key Takeaways for Senior Stakeholders

  • Therapy paradigms are shifting towards highly individualized care, with precision medicine and immunotherapy redefining treatment protocols and improving durability of responses.
  • Multidisciplinary collaboration in oncology, surgery, and radiotherapy is critical for optimizing patient outcomes and maximizing resource utilization across different care settings.
  • Advances in digital health and real-world evidence collection are accelerating the adoption of new modalities and helping align patient pathways with emerging clinical data.
  • Regional disparities in adoption, access, and reimbursement require tailored business models to ensure effective market entry and sustained growth.
  • Strategic alliances with domestic manufacturers and technology partners are becoming essential to bolster supply chain resilience and adapt to regulatory or economic shifts.

Tariff Impact: Navigating New Barriers and Opportunities

  • Recent tariff adjustments in 2025 are expected to impact the importation and pricing of both pharmaceutical compounds and bioprocessing equipment for gastric cancer therapies.
  • Escalating duties may elevate production costs, compelling stakeholders to renegotiate procurement and supply contracts.
  • Manufacturers are likely to pursue regionalized sourcing and domestic capacity expansion to counteract volatility and maintain uninterrupted treatment delivery.
  • Health systems and payers must reassess formulary designs and support programs to offset shifts in patient affordability and therapy access, especially where out-of-pocket costs are significant.

Research Methodology & Data Sources

This report employs extensive secondary research from peer-reviewed journals, regulatory documents, and clinical trial databases, followed by primary interviews with clinicians, pharmacoeconomists, and supply chain experts. Quantitative surveys and stakeholder engagement ensure the reliability, depth, and operational relevance of each insight presented in the analysis.

Why This Report Matters

  • Equips executives with validated intelligence to anticipate therapeutic shifts and regulatory changes in the stomach cancer treatment market.
  • Enables strategic planning with in-depth segmentation, technology adoption analysis, and competitive landscape profiling.
  • Supports informed resource allocation, partnership decisions, and market entry strategies within varied geographic, regulatory, and clinical contexts.

Conclusion

This research delivers pragmatic guidance for stakeholders navigating evolving therapies, policy reforms, and operational challenges in the global gastric cancer market. Leverage these strategic insights to align clinical and business objectives for sustainable, patient-centered innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of PD-1 and PD-L1 inhibitors in first-line gastric cancer treatment
5.2. Integration of molecular biomarker screening to personalize gastric cancer therapies
5.3. Increasing use of liquid biopsy for early detection and monitoring of tumor recurrence
5.4. Development of FGFR2 targeting agents for advanced gastric cancer patients with receptor amplification
5.5. Expansion of minimally invasive robotic surgery to improve postoperative outcomes in gastric cancer
5.6. Utilization of real-world evidence to optimize treatment sequencing in metastatic gastric cancer
5.7. Growth of combination immunotherapy and chemotherapy regimens in advanced stomach cancer management
5.8. Rising investment in AI-enabled endoscopic systems to enhance early gastric cancer diagnosis accuracy
5.9. Emergence of CAR-T cell therapies targeting Claudin 18.2 in refractory gastric tumors
5.10. Impact of evolving reimbursement policies on accessibility of novel gastric cancer treatments across markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stomach Cancer Treatment Market, by Treatment Type
8.1. Introduction
8.2. Chemotherapy
8.2.1. Fluorouracil-Based
8.2.2. Platinum-Based
8.2.3. Taxane-Based
8.3. Immunotherapy
8.3.1. Ctla-4 Inhibitors
8.3.2. Pd-1 Inhibitors
8.4. Radiotherapy
8.4.1. Brachytherapy
8.4.2. External Beam
8.5. Surgery
8.5.1. Partial Gastrectomy
8.5.2. Total Gastrectomy
8.6. Targeted Therapy
8.6.1. Egfr Inhibitors
8.6.2. Her2 Inhibitors
8.6.3. Vegf Inhibitors
9. Stomach Cancer Treatment Market, by Route Of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
10. Stomach Cancer Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Stomach Cancer Treatment Market, by Stage
11.1. Introduction
11.2. Stage I
11.3. Stage Ii
11.4. Stage Iii
11.5. Stage Iv
12. Stomach Cancer Treatment Market, by End User
12.1. Introduction
12.2. Homecare
12.3. Hospitals
12.4. Specialty Clinics
13. Stomach Cancer Treatment Market, by Histologic Type
13.1. Introduction
13.2. Adenocarcinoma
13.3. Carcinoid Tumors
13.4. Gist
13.5. Lymphoma
14. Americas Stomach Cancer Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Stomach Cancer Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Stomach Cancer Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche AG
17.3.2. Bristol-Myers Squibb Company
17.3.3. Merck Sharp & Dohme Corp.
17.3.4. AstraZeneca PLC
17.3.5. Novartis AG
17.3.6. Takeda Pharmaceutical Company Limited
17.3.7. Daiichi Sankyo Company, Limited
17.3.8. Sanofi S.A.
17.3.9. Pfizer Inc.
17.3.10. Amgen Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STOMACH CANCER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STOMACH CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STOMACH CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. STOMACH CANCER TREATMENT MARKET: RESEARCHAI
FIGURE 28. STOMACH CANCER TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. STOMACH CANCER TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. STOMACH CANCER TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. STOMACH CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY FLUOROURACIL-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY FLUOROURACIL-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PLATINUM-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PLATINUM-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TAXANE-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TAXANE-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CTLA-4 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CTLA-4 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PD-1 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PARTIAL GASTRECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY PARTIAL GASTRECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TOTAL GASTRECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TOTAL GASTRECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HER2 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HER2 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY VEGF INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY VEGF INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CARCINOID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY CARCINOID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY GIST, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY GIST, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 148. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 149. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 150. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 151. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 152. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 153. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 154. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 155. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 156. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 157. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 162. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 163. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 290. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 291. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2018-2024 (USD MILLION)
TABLE 300. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY HISTOLOGIC TYPE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 304. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 306. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 307. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 312. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 313. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2018-2024 (USD MILLION)
TABLE 318. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY STAGE, 2025-2030 (USD MILLION)
TABLE 319. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. FRANCE STOMACH CANCER TREAT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Stomach Cancer Treatment market report include:
  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • AstraZeneca PLC
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Daiichi Sankyo Company, Limited
  • Sanofi S.A.
  • Pfizer Inc.
  • Amgen Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.64 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Stomach Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Disease Indication, By Route Of Administration, By Drug Class, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Stomach Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Disease Indication, By Route Of Administration, By Drug Class, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Gastric Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Image

Gastric Cancer Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
HER2-positive Gastric Cancer- Pipeline Insight, 2025 - Product Image

HER2-positive Gastric Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Gastric Cancer Drug Pipeline Analysis Report 2025 - Product Image

Gastric Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.